Gene · 8826
Papers2,407
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,407
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Interaction between Chemokine and Phosphoinositide Signaling in Metastatic Prostate Cancer. | Med Res Arch | 2023 | 38239314 | PubTator, text mining | PubMed |
| Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies. | Front Immunol | 2023 | 38235128 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections. | Int J Mol Sci | 2023 | 38203503 | PubTator, text mining | PubMed |
| Molecular Insight into Gastric Cancer Invasion-Current Status and Future Directions. | Cancers (Basel) | 2023 | 38201481 | PubTator, text mining | PubMed |
| Update on current diagnosis and management of anaplastic thyroid carcinoma. | World J Clin Oncol | 2023 | 38179406 | PubTator, text mining | PubMed |
| The current status and future of PD-L1 in liver cancer. | Front Immunol | 2023 | 38155974 | PubTator, text mining | PubMed |
| Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment. | Front Endocrinol (Lausanne) | 2023 | 38116315 | PubTator, text mining | PubMed |
| Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis. | Cancer Cell Int | 2023 | 38104099 | PubTator, text mining | PubMed |
| Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer. | J Exp Clin Cancer Res | 2023 | 38102637 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer. | Sci Rep | 2023 | 38097783 | PubTator, text mining | PubMed |
| Regulatory mechanism of macrophage polarization based on Hippo pathway. | Front Immunol | 2023 | 38090595 | PubTator, text mining | PubMed |
| An integrated method for single cell proteomics with simultaneous measurements of intracellular drug concentration implicates new mechanisms for adaptation to KRASG12D inhibitors. | bioRxiv | 2023 | 38014353 | PubTator, text mining | PubMed |
| Neo-Antigen-Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach. | Glob Chall | 2023 | 37970536 | PubTator, text mining | PubMed |
| Comprehensive analysis of disulfidptosis related genes and prognosis of gastric cancer. | World J Clin Oncol | 2023 | 37970110 | PubTator, text mining | PubMed |
| MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner. | J Exp Clin Cancer Res | 2023 | 37926835 | PubTator, text mining | PubMed |
| Editorial: Exploiting genetics and genomics to improve the understanding of eye diseases. | Front Genet | 2023 | 37920854 | PubTator, text mining | PubMed |
| Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies. | Cancer Cell Int | 2023 | 37919768 | PubTator, text mining | PubMed |
| FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review. | Front Oncol | 2023 | 37916161 | PubTator, text mining | PubMed |
| Autophagy gene-dependent intracellular immunity triggered by interferon-γ. | mBio | 2023 | 37905813 | PubTator, text mining | PubMed |
| Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software. | Int J Mol Sci | 2023 | 37894929 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8826/papers?page=8